Investors

MolMed: the protocol of the in-man trial on CAR T CD44v6 presented at EHA (European Hematology Association) in Paris.
MolMed: the protocol of the in-man trial on CAR T CD44v6 presented at EHA (European Hematology Association) in Paris.

News & Events

Stay update
Presentation of the First Italian Report on the ATMP (Advanced Therapy Medicinal Product)

Presentation of the First Italian Report on the ATMP (Advanced Therapy Medicinal Product)

Location: Roma

MolMed at this event: Intervento Riccardo Palmisano

Investors

MolMed and Dompé announce the mutual termination of the license and distribution agreement for Zalmoxis®
MolMed and Dompé announce the mutual termination of the license and distribution agreement for Zalmoxis®